Sitagliptin in pharma franchise in Hyderabad

Sitagliptin in PCD pharma franchise in Odisha

Sitagliptin in top pharma company in Jaipur

Sitagliptin in pcd pharma supplier in Tamil Nadu

Sitagliptin in phama franchise company in india
Sitagliptin in phama distributor in Lucknow

Home/Products /sitagliptin-phosphate-i-p-100mg-dapagliflozin-propanediol-u-s-p-10mg-tablets

About the Product

Description


Istalab D Tablet is a potent combination medication that includes Sitagliptin Phosphate I.P. at a dosage of 100 mg and Dapagliflozin Propanediol U.S.P. at 10 mg. This innovative formulation is specifically designed for the management of type 2 diabetes mellitus in adults. Sitagliptin, a DPP-4 inhibitor, enhances the body’s ability to regulate blood sugar levels by increasing insulin secretion in response to meals and decreasing glucagon levels, which helps to lower glucose production in the liver. Dapagliflozin, a sodium-glucose co-transporter 2 (SGLT2) inhibitor, works by preventing the reabsorption of glucose in the kidneys, leading to increased glucose excretion through urine. This dual mechanism of action not only helps in achieving better glycemic control but also offers additional benefits such as weight loss and a reduction in blood pressure.

The combination of Sitagliptin and Dapagliflozin in Istalab D Tablet provides a comprehensive approach to diabetes management, making it particularly suitable for patients who require more than one medication to control their blood sugar levels effectively. This combination therapy is beneficial for individuals who may have not achieved adequate glycemic control with monotherapy or those who are starting treatment for the first time. By addressing multiple pathways involved in glucose metabolism, Istalab D Tablet helps patients maintain stable blood sugar levels, which is crucial for preventing the long-term complications associated with diabetes.

While Istalab D Tablet is generally well-tolerated, some patients may experience side effects. Common adverse reactions include urinary tract infections, genital mycotic infections, gastrointestinal disturbances such as nausea, and headache. Rare but serious side effects may include dehydration, kidney problems, and pancreatitis. Patients should be vigilant for symptoms such as excessive thirst, frequent urination, or abdominal pain and should seek medical attention if these arise.

For optimal storage, Istalab D Tablet should be kept in a cool, dry place, away from direct sunlight and moisture. It is essential to store this medication out of reach of children and pets to prevent accidental ingestion.

Common side effects may include urinary tract infections, gastrointestinal disturbances, and headache. Serious side effects should be reported to a healthcare provider.

Istalab D Tablet is indicated for the management of type 2 diabetes mellitus in adults.

Consult a healthcare professional before starting this medication, especially if you have a history of kidney issues or pancreatitis.

Store in a cool, dry place away from sunlight and moisture

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

1. What are the business opportunities for Sitagliptin Phosphate 100 mg + Dapagliflozin Propanediol 10 mg Tablet in the PCD pharma franchise market?

Sitagliptin + Dapagliflozin Tablet is a premium product in the diabetology, endocrinology, and chronic care segment, making it a valuable addition to a PCD pharma franchise portfolio. With the rising prevalence of Type 2 Diabetes and increasing preference for advanced combination therapies, this formulation enjoys strong prescription demand from diabetologists, endocrinologists, physicians, hospitals, and healthcare institutions across India.

2. Why should medical distributors include Sitagliptin + Dapagliflozin Tablet in their product range?

Medical distributors and franchise partners can benefit from the growing demand for modern diabetic care therapies. Commonly prescribed for the management of Type 2 Diabetes under medical supervision Combines two widely prescribed antidiabetic agents in a single convenient formulation Frequently recommended by diabetologists, endocrinologists, and physicians Strong demand across hospitals, clinics, and retail pharmacy channels Long-term therapy contributes to consistent repeat prescriptions Supports expansion into the rapidly growing diabetic and metabolic care segment This strengthens a comprehensive diabetic and chronic care product portfolio.

3. Does Cafoli LifeCare Pvt Ltd offer PCD pharma franchise opportunities for this product?

Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Sitagliptin Phosphate 100 mg + Dapagliflozin Propanediol 10 mg Tablet with exclusive monopoly rights, promotional support, attractive packaging, and competitive pricing for distributors, stockists, and wholesalers across India.

4. What benefits do wholesalers get by partnering for this product?

Wholesalers and medical agencies can benefit from: Strong prescription demand in the diabetic care segment Growing acceptance of advanced combination therapies High repeat-order potential due to chronic therapy usage Reliable product availability and supply chain support Attractive business margins and long-term growth opportunities Expanding diabetes management market across India These advantages contribute to sustainable sales growth and business expansion.

5. How can I become a distributor or franchise partner for this product?

Interested distributors, stockists, and pharma entrepreneurs can partner with Cafoli LifeCare Pvt Ltd to access profitable PCD pharma franchise opportunities for Sitagliptin Phosphate 100 mg + Dapagliflozin Propanediol 10 mg Tablet. With exclusive monopoly rights, comprehensive promotional support, quality-assured formulations, attractive profit margins, and dependable logistics services, Cafoli LifeCare Pvt Ltd helps franchise partners establish and expand a successful pharmaceutical business across India.